Work

Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease

Year: 2022
Type: review
Abstract: -synuclein as a key pathogenic protein in this disease as well as in dementia with Lewy bodies, making it of leading therapeutic interest. This review discusses the various approaches being investigated and progress made to date toward discovering and developing therapeutics that would slow and stop progression of these disabling diseases.
Institution: Rutgers Health
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W4206464678
FWCI: 2.93
Cites: 346
Cited by: 110
Related to: 10